(11/9) 銘柄メモ機能をリリースしました。

(10/31) 当日の決算短信・業績予想の修正にPER/PBRが表示されるようにしました。

9776 札幌臨床検査センター

会員登録をしてログインすると、銘柄メモを保存できます。

累計 / 通期:4Q / 3Q / 2Q / 1Q
全期間を表示
決算期四半期売上高営業利益営業
利益率
経常利益経常
利益率
純利益
利益率
EPS売上高
前年比
営業利益
前年比
経常利益
前年比
純利益
前年比
2026/03予想20,6887753.7%7713.7%5052.4%162.13----
2026/032Q10,2383793.7%3893.8%2502.4%80.402.4%12.5%13.4%12.6%
2026/031Q5,066871.7%931.8%470.9%15.321.3%-11.2%-8.8%-16.1%
2025/034Q20,1317063.5%7073.5%4642.3%148.352.3%32.2%37.5%22.1%
2025/033Q15,2755413.5%5533.6%3672.4%117.222.8%30.7%32.6%18.0%
2025/032Q9,9963373.4%3433.4%2222.2%70.871.4%15.8%15.9%-1.8%
2025/031Q4,999982.0%1022.0%561.1%17.901.6%30.7%27.5%1,020.0%
2024/034Q19,6825342.7%5142.6%3801.9%114.14-2.2%-47.0%-55.7%-33.1%
2024/033Q14,8524142.8%4172.8%3112.1%93.67-2.6%-49.3%-57.1%-36.9%
2024/032Q9,8622913.0%2963.0%2262.3%67.94-1.0%-40.9%-49.7%-12.4%
2024/031Q4,922751.5%801.6%50.1%1.720.4%-42.7%-64.1%-93.6%
2023/034Q20,1271,0085.0%1,1595.8%5682.8%170.535.3%-34.4%-27.8%-45.5%
2023/033Q15,2508165.4%9716.4%4933.2%147.856.8%-24.9%-14.7%-25.4%
2023/032Q9,9644924.9%5895.9%2582.6%77.374.2%-36.7%-28.2%-43.5%
2023/031Q4,9001312.7%2234.6%781.6%23.355.6%-55.1%-23.9%-27.1%
2022/034Q19,1091,5378.0%1,6058.4%1,0425.5%306.169.2%34.6%35.1%31.4%
2022/033Q14,2851,0867.6%1,1398.0%6614.6%193.9610.0%45.2%50.1%36.9%
2022/032Q9,5667778.1%8208.6%4574.8%134.1314.4%111.1%118.1%103.1%
2022/031Q4,6382926.3%2936.3%1072.3%31.3113.8%784.8%651.3%黒転
2021/034Q17,5021,1426.5%1,1886.8%7934.5%231.85-0.9%21.0%21.0%50.2%
2021/033Q12,9857485.8%7595.8%4833.7%141.17-2.7%2.6%-0.4%-2.4%
2021/032Q8,3643684.4%3764.5%2252.7%65.88-5.4%-25.2%-26.0%-31.0%
2021/031Q4,074330.8%391.0%-1--0.39-8.0%-87.6%-85.6%赤転
2020/034Q17,6599445.3%9825.6%5283.0%154.303.5%15.8%20.8%1.0%
2020/033Q13,3457295.5%7625.7%4953.7%144.783.6%28.3%30.0%31.0%
2020/032Q8,8384925.6%5085.7%3263.7%95.254.8%54.7%53.9%58.3%
2020/031Q4,4262676.0%2716.1%1794.0%52.56----
2019/034Q17,0658154.8%8134.8%5233.1%152.42----
2019/033Q12,8785684.4%5864.6%3782.9%110.24----
2019/032Q8,4333183.8%3303.9%2062.4%60.05----

四半期

決算期四半期売上高営業利益営業
利益率
経常利益経常
利益率
純利益
利益率
EPS売上高
前年比
営業利益
前年比
経常利益
前年比
純利益
前年比
2026/033Q-4Q 予想10,4503963.8%3823.7%2552.4%81.73----
2026/032Q5,1722925.6%2965.7%2033.9%65.083.5%22.2%22.8%22.3%
2026/031Q5,066871.7%931.8%470.9%15.321.3%-11.2%-8.8%-16.1%
2025/034Q4,8561653.4%1543.2%972.0%31.130.5%37.5%58.8%40.6%
2025/033Q5,2792043.9%2104.0%1452.7%46.355.8%65.9%73.6%70.6%
2025/032Q4,9972394.8%2414.8%1663.3%52.971.2%10.6%11.6%-24.9%
2025/031Q4,999982.0%1022.0%561.1%17.901.6%30.7%27.5%1,020.0%
2024/034Q4,8301202.5%972.0%691.4%20.47-1.0%-37.5%-48.4%-8.0%
2024/033Q4,9901232.5%1212.4%851.7%25.73-5.6%-62.0%-68.3%-63.8%
2024/032Q4,9402164.4%2164.4%2214.5%66.22-2.4%-40.2%-41.0%22.8%
2024/031Q4,922751.5%801.6%50.1%1.720.4%-42.7%-64.1%-93.6%
2023/034Q4,8771923.9%1883.9%751.5%22.681.1%-57.4%-59.7%-80.3%
2023/033Q5,2863246.1%3827.2%2354.4%70.4812.0%4.9%19.7%15.2%
2023/032Q5,0643617.1%3667.2%1803.6%54.022.8%-25.6%-30.6%-48.6%
2023/031Q4,9001312.7%2234.6%781.6%23.355.6%-55.1%-23.9%-27.1%
2022/034Q4,8244519.3%4669.7%3817.9%112.206.8%14.5%8.6%22.9%
2022/033Q4,7193096.5%3196.8%2044.3%59.832.1%-18.7%-16.7%-20.9%
2022/032Q4,9284859.8%52710.7%3507.1%102.8214.9%44.8%56.4%54.9%
2022/031Q4,6382926.3%2936.3%1072.3%31.3113.8%784.8%651.3%黒転
2021/034Q4,5173948.7%4299.5%3106.9%90.684.7%83.3%95.0%839.4%
2021/033Q4,6213808.2%3838.3%2585.6%75.292.5%60.3%50.8%52.7%
2021/032Q4,2903357.8%3377.9%2265.3%66.27-2.8%48.9%42.2%53.7%
2021/031Q4,074330.8%391.0%-1--0.39-8.0%-87.6%-85.6%赤転
2020/034Q4,3142155.0%2205.1%330.8%9.523.0%-13.0%-3.1%-77.2%
2020/033Q4,5072375.3%2545.6%1693.7%49.531.4%-5.2%-0.8%-1.7%
2020/032Q4,4122255.1%2375.4%1473.3%42.69-47.7%-29.2%-28.2%-28.6%
2020/031Q4,4262676.0%2716.1%1794.0%52.56----
2019/034Q4,1872475.9%2275.4%1453.5%42.18----
2019/033Q4,4452505.6%2565.8%1723.9%50.19----
2019/032Q8,4333183.8%3303.9%2062.4%60.05----